These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35922447)

  • 1. Targeting SARS-CoV-2 endoribonuclease: a structure-based virtual screening supported by in vitro analysis.
    Ibrahim IM; Elfiky AA; Fathy MM; Mahmoud SH; ElHefnawi M
    Sci Rep; 2022 Aug; 12(1):13337. PubMed ID: 35922447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structural-based virtual screening and
    Ibrahim IM; Elfiky AA; Mahmoud SH; ElHefnawi M
    J Biomol Struct Dyn; 2024 Oct; 42(17):9145-9158. PubMed ID: 37615430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition.
    Savale RU; Bhowmick S; Osman SM; Alasmary FA; Almutairi TM; Abdullah DS; Patil PC; Islam MA
    Arch Biochem Biophys; 2021 Mar; 700():108771. PubMed ID: 33485847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential target endoribonuclease NSP15 inhibitors of SARS-COV-2 from natural products through high-throughput virtual screening and molecular dynamics simulation.
    Hu LC; Ding CH; Li HY; Li ZZ; Chen Y; Li LP; Li WZ; Liu WS
    J Food Biochem; 2022 May; 46(5):e14085. PubMed ID: 35128681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing.
    Al-Rashedi NAM; Munahi MG; Ah ALObaidi L
    J Biomol Struct Dyn; 2022 Jul; 40(11):4879-4892. PubMed ID: 33357040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Persuasive Antiviral Natural Compounds for COVID-19 by Targeting Endoribonuclease NSP15: A Structural-Bioinformatics Approach.
    Saeed M; Saeed A; Alam MJ; Alreshidi M
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33271751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme.
    Ahmad S; Waheed Y; Ismail S; Bhatti S; Abbasi SW; Muhammad K
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach.
    Batool A; Bibi N; Amin F; Kamal MA
    Eur J Pharmacol; 2021 Feb; 892():173779. PubMed ID: 33275961
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
    J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity.
    Choi R; Zhou M; Shek R; Wilson JW; Tillery L; Craig JK; Salukhe IA; Hickson SE; Kumar N; James RM; Buchko GW; Wu R; Huff S; Nguyen TT; Hurst BL; Cherry S; Barrett LK; Hyde JL; Van Voorhis WC
    PLoS One; 2021; 16(4):e0250019. PubMed ID: 33886614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease.
    Canal B; Fujisawa R; McClure AW; Deegan TD; Wu M; Ulferts R; Weissmann F; Drury LS; Bertolin AP; Zeng J; Beale R; Howell M; Labib K; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2465-2479. PubMed ID: 34198324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies.
    Roy R; Sk MF; Jonniya NA; Poddar S; Kar P
    J Biomol Struct Dyn; 2022 Sep; 40(14):6556-6568. PubMed ID: 33682642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of natural compounds against the activity of SARS-CoV-2 NSP15 protein towards an effective treatment against COVID-19: a theoretical and computational biology approach.
    Motwalli O; Alazmi M
    J Mol Model; 2021 May; 27(6):160. PubMed ID: 33963942
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15.
    Shalayel MH; Al-Mazaideh GM; Aladaileh SH; Al-Swailmi FK; Al-Thiabat MG
    Pak J Pharm Sci; 2020 Sep; 33(5):2179-2186. PubMed ID: 33824127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of nonstructural protein 15 of SARS-CoV-2 by golden spice: A computational insight.
    Singh R; Bhardwaj VK; Purohit R
    Cell Biochem Funct; 2022 Dec; 40(8):926-934. PubMed ID: 36203381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the hexamerization of SARS-CoV-2 endoribonuclease and modeling of RNA structures bound to the hexamer.
    Tran DP; Taira Y; Ogawa T; Misu R; Miyazawa Y; Kitao A
    Sci Rep; 2022 Mar; 12(1):3860. PubMed ID: 35264667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repositioning to target NSP15 protein on SARS-CoV-2 as possible COVID-19 treatment.
    Sixto-López Y; Martínez-Archundia M
    J Comput Chem; 2021 May; 42(13):897-907. PubMed ID: 33713492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-guided pharmacophore based virtual screening, docking, and molecular dynamics to discover repurposed drugs as novel inhibitors against endoribonuclease Nsp15 of SARS-CoV-2.
    Jha P; Saluja D; Chopra M
    J Biomol Struct Dyn; 2023 Jul; 41(11):5096-5106. PubMed ID: 35652904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
    Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
    J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.